Comparison of IVR and CATI Surveys in Bangladesh
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04508010 |
|
Recruitment Status :
Recruiting
First Posted : August 11, 2020
Last Update Posted : March 23, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Surveys and Questionnaires Non Communicable Diseases | Other: IVR Other: CATI | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 6160 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Masking Description: | Data cleaning and analysis will be conducted by a statistician blinded to the study arm |
| Primary Purpose: | Other |
| Official Title: | Comparison of Interactive Voice Response (IVR) and Computer-assisted Telephone Interview (CATI) Mobile Phone Surveys for Non-communicable Disease Risk Factor Surveillance in Bangladesh |
| Actual Study Start Date : | August 25, 2020 |
| Estimated Primary Completion Date : | April 2021 |
| Estimated Study Completion Date : | April 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: IVR survey
Participants will receive an IVR survey
|
Other: IVR
Participants will receive an IVR survey |
|
Experimental: CATI survey
Participants will receive a CATI survey
|
Other: CATI
Participants will receive a CATI survey |
- Cooperation Rate #1 [ Time Frame: Through study completion, an average of one month ]As defined by American Association for Public Opinion Research, cooperation rate is defined as I/(I+P+R) where I is complete interviews, P is partial interviews, and R is refusals and breakoffs
- Response Rate #4 [ Time Frame: Time Frame: Through study completion, an average of one month ]As defined by American Association for Public Opinion Research, response rate is defined as (I+P)/(I+P+R+eU) where I is complete interviews, P is partial interviews, R is refusals and breakoffs, and eU is the estimated eligible proportion of unknowns
- Contact Rate #2 [ Time Frame: Through study completion, an average of one month ]As defined by American Association for Public Opinion Research, contact rate is defined as (I+P+R)/(I+P+R+eU) where I is complete interviews, P is partial interviews, R is refusals and breakoffs, and eU is the estimated eligible proportion of unknowns
- Refusal Rate #2 [ Time Frame: Through study completion, an average of one month ]As defined by American Association for Public Opinion Research, refusal rate is defined as (R)/(I+P+R+eU) where R is refusals and breakoffs, I is complete interviews, P is partial interviews, and eU is the estimated eligible proportion of unknowns
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Access to a mobile phone
- Greater or equal to 18 years of age
- In Bangladesh, conversant in Bengali language
Exclusion Criteria:
- Less than 18 years of age
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04508010
| Contact: Vidhi Maniar, MPH | 4106144730 | vmaniar1@jh.edu | |
| Contact: Dustin Gibson, PhD | 4432878763 | dgibso28@jhu.edu |
| Bangladesh | |
| Institute of Epidemiology, Disease Control and Research | Recruiting |
| Dhaka, Bangladesh | |
| Contact: Iqbal Khan, PhD | |
| Principal Investigator: | Dustin Gibson, PhD | Johns Hopkins University Bloomberg School of Public Health | |
| Principal Investigator: | Iqbal Khan, PhD | Institute of Epidemiology, Disease Control and Research |
| Responsible Party: | Johns Hopkins Bloomberg School of Public Health |
| ClinicalTrials.gov Identifier: | NCT04508010 |
| Other Study ID Numbers: |
00007318 - Bangladesh |
| First Posted: | August 11, 2020 Key Record Dates |
| Last Update Posted: | March 23, 2021 |
| Last Verified: | March 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
mobile phone surveys interactive voice response |
|
Noncommunicable Diseases Disease Attributes Pathologic Processes |

